Indoco Remedies Q2 Results: Net profit at ₹19.5 Crore, revenue rises 7%

What happened

Indoco Remedies reported a net profit of ₹19.5 crore for the second quarter, compared with a net loss of ₹9.2 crore a year earlier. Revenue rose 7.4% to ₹507 crore, and shares were trading 3.42% higher at ₹227.

Confirmed

Global impact / market context

Returning to profit after a year-earlier loss shows the company is earning more than it spends again. Higher revenue and improved EBITDA, which means earnings before interest, tax, depreciation and amortization, can support cash available for operations and reduce pressure on borrowed money.

Analyst inference

The share price rose on results day, yet the stock is still down about 1% in 2026, suggesting investors remain cautious over the year despite this quarter's improvement. A thin EBITDA margin of 6.5% leaves limited cushion if costs rise.

Analyst inference

What to watch

1. Watch whether revenue growth of 7.4% continues, since it drove the quarter's improvement alongside a small rise in EBITDA margin to 6.5% from 6.4%. Confirmed
2. Watch for company plans on capital spending, which means money put into factories and equipment, because such outlays could affect future revenue and cash available. Proposed
3. Watch whether the return to profit holds in coming quarters; a repeat loss would challenge the view that the business has turned a corner and could weigh on the share price. Analyst inference

Evidence

• Original source link unavailable